Sen. Bernie Sanders (I-Vt.) urged the CEOs of OpenAI, Anthropic, and Meta to pause artificial intelligence development on Monday [1].

The demand marks a significant escalation in the legislative push to regulate emerging technologies. If the industry refuses to self-regulate, the senator said that the U.S. government will move to impose mandates via Congress [2].

Sanders addressed the request to Sam Altman of OpenAI, Dario Amodei of Anthropic, and Mark Zuckerberg of Meta [1]. He argued that the current trajectory of the industry risks creating systems that operate beyond human oversight. The senator said that the pause is necessary to avoid a potential catastrophe [2].

"Mr. Altman, Mr. Amodei and Mr. Zuckerberg: In the interest of humanity, stand by your words. Pause AI development," Sanders said [1]. "It is not too late to avoid disaster."

The senator's call focuses on the safety and controllability of advanced models. He emphasized the danger of the current pace of innovation, which he believes could outstrip the ability of regulators and developers to maintain safety protocols [3].

"Stop building machines that humans cannot control," Sanders said [3].

While the tech leaders have previously discussed the risks associated with AI, the senator said that their public warnings have not translated into operational changes. He said that the time for voluntary caution has passed [1].

He concluded his demand with a direct warning regarding legislative consequences. "If you do not pause, Congress will step in and take action," Sanders said [2].

"Stop building machines that humans cannot control."

This move signals a shift from cautious inquiry to direct confrontation between the U.S. Senate and Silicon Valley. By targeting the three most influential AI labs simultaneously, Sanders is attempting to create a unified regulatory front. If these companies ignore the request, it likely paves the way for more aggressive federal legislation targeting AI training and deployment, moving the U.S. closer to a restrictive regulatory model similar to those being explored in the European Union.